Semrau, S.; Gostian, A.-O.; Traxdorf, M.; Eckstein, M.; Rutzner, S.; von der Grün, J.; Illmer, T.; Hautmann, M.; Klautke, G.; Laban, S.;
et al. Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. Cancers 2021, 13, 1959.
https://doi.org/10.3390/cancers13081959
AMA Style
Semrau S, Gostian A-O, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann M, Klautke G, Laban S,
et al. Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. Cancers. 2021; 13(8):1959.
https://doi.org/10.3390/cancers13081959
Chicago/Turabian Style
Semrau, Sabine, Antoniu-Oreste Gostian, Maximilian Traxdorf, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias Hautmann, Gunther Klautke, Simon Laban,
and et al. 2021. "Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer" Cancers 13, no. 8: 1959.
https://doi.org/10.3390/cancers13081959
APA Style
Semrau, S., Gostian, A.-O., Traxdorf, M., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., Hautmann, M., Klautke, G., Laban, S., Brunner, T., Tamaskovics, B., Frey, B., Zhou, J.-G., Geppert, C.-I., Hartmann, A., Balermpas, P., Budach, W., Gaipl, U.,
... Hecht, M.
(2021). Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. Cancers, 13(8), 1959.
https://doi.org/10.3390/cancers13081959
